AMERICAN FORK, Utah, April 30, 2024 (GLOBE NEWSWIRE) — OrthoSelect, a leading orthodontics software company and digital orthodontics laboratory, announces the release of DIBS AI 8.0. Already an innovator in digital indirect bonding, DIBS AI has taken treatment to the next level in providing orthodontists a powerful tool to shorten treatment times and improve case outcomes.
Key new features in DIBS AI 8.0 include:
To learn more about DIBS AI 8.0 and how DIBS AI can transform your practice, please visit www.DIBSAI.com, call +1 801-763-5039, or email sales@dibsai.com.
Also, come visit us at Booth #2219 at the upcoming 2024 AAO Annual Session at the Ernest N. Morial Convention Center in New Orleans, LA on May 4-6.
About DIBS AI
The DIBS AI software platform simplifies and automates the process of orthodontic patient case setups and treatment. DIBS AI software creates predictive outcomes based on any desired bracket prescription, so practitioners can truly begin with the end in mind. It also provides the flexibility to 3D print, either in-house or in our lab, extremely accurate bracket transfer appliances (commonly known as IDB trays). These advancements free up precious doctor, staff, and chair time by shortening bonding appointments by a third or more, as well as reducing overall treatment time through significant decreases in wire bending and bracket repositioning. The benefits in improved accuracy and time savings can result in a reduction of 25% or more of the orthodontist’s cost of treatment.
DIBS has received FDA clearance under section 510(k) of the Federal Food, Drug, and Cosmetic Act. DIBS AI has been patented with the USPTO, and is a registered trademark of OrthoSelect, LLC.
Apple® is a registered trademark of Apple Inc.
CONTACT: For OrthoSelect media inquiries, please contact Milan Detweiler at: milan@myorthoselect.com.
Milestone enables GMP manufacturing to accelerate clinical trials and transform global vaccine delivery BRISBANE, Australia…
BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading…
12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel…
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…
The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process…